Did you know what Richard Pryor referred to Multiple Sclerosis as?

Yesterday one of my colleagues wrote a great article about multiple sclerosis (MS) clinical trials, so on this beautiful sunday morning in New York as I watch one of Richard Pyror’s shows, I thought of writing about one of the greatest comedian, his 17-year fight against multiple sclerosis and the new treatments that are being developed through clinical trials. Richard Pryor, regarded as the Picasso of comedy, was well known breaking racial barriers by regularly examining racial issues in his shows. A winner of several grammy awards, Richard Pyror was diagnosed with multiple sclerosis in 1986, and suffered a severe heart attack in 1990.

Multiple Sclerosis is a disease in which the protective sheaths around the nerves of the brain and spinal cord are irreversibly damaged. The infected person experiences interferences and deterioration of functions controlled by the nervous system such as speech, memory, walking, writing and vision. Although there are several treatments and clinical trials going on, researchers are yet to ascertain a cause for multiple sclerosis. Some of the currently on-going clinical trials are:

You can see a full list of active multiple sclerosis clinical trials here, by treatments such as methylprednisolone, teriflunomide, memantine and rebif, or by doctors who are known to conduct multiple sclerosis clinical trials.

Richard Pryor passed away due to cardiac arrest in 2005, after a 17-year battle against multiple sclerosis. Often joking about his condition, he referred to multiple sclerosis (MS) as “More Shit”. Let’s hope that we can all work together to eradicate this slow and debilitating disease!

Related posts:

  1. Multiple Sclerosis: Bike, Walk and Clinical Trials for a New Cure
  2. Lisa Ray Fights Multiple Myeloma!
  3. Kylie Minogue beat breast cancer, you can too!
  4. Struggling with weight problems or obesity? Tackle them head-on with Michelle Obama and Oprah Winfrey!
  5. Steve Jobs is No more. Long battle with Pancreatic Cancer takes its toll